L-028

Lisdexamfetamin-D₄ Dimesylat -Lösung

100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant^®

• Synonym(e): Lisdexamfetamin-d4-dimesylat -Lösung
• Empirische Formel (Hill-System): C₁₅H₂₁D₄N₃O · C₂H₆S₂O₆H₂
• Molekulargewicht: 459.61
• EG-Nummer: 200-659-6
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: certified reference material
• Form: liquid
• Leistungsmerkmale: Snap-N-Spike^®/Snap-N-Shoot^®
• Verpackung: ampule of 1 mL
• Hersteller/Markenname: Cerilliant^®
• drug control: Narcotic Licence Schedule A (Switzerland)
• Konzentration: 100 μg/mL in methanol (as free base)
• Methode(n): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Anwendung(en): forensics and toxicology
• Format: single component solution
• Lagertemp.: −20°C
• SMILES String: CS(O)(=O)=O.CS(O)(=O)=O.[2H]C([2H])(CN)C([2H])([2H])C[C@H](N)C(=O)N[C@@H](C)Cc1ccccc1
• InChI: 1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1/i5D2,6D2;;
• InChIKey: CETWSOHVEGTIBR-DIDVIBMPSA-N

Beschreibung

Allgemeine Beschreibung

A certified solution standard suitable for quantitation of lisdexamfetamine in urine or other biological samples by GC/MS or LC/MS in clinical toxicology testing, forensic analysis, urine drug testing, or pharmaceutical research. Lisdexamfetamine, a psychostimulant prodrug of dextroamphetamine, is marketed as the drug Vyvanse^® for treatment of attention deficit hyperactivity disorder (ADHD) in adults and children six to twelve years of age.

Anwendung

• Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder: This population-based cohort study in Denmark and Sweden leverages Lisdexamfetamine-D₄ to investigate cardiovascular risks associated with ADHD medications, demonstrating its critical role in safety and efficacy assessments (Forns J et al., 2022).

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Vyvanse is a registered trademark of Shire, LLC

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H225,H301 + H311 + H331,H370
• P-Sätze: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Zielorgane: Eyes
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 1
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup